ADGC Publications

Found 160 results
Filters: Keyword is Humans  [Clear All Filters]
2019
Patel D, Mez J, Vardarajan BN, Staley L, Chung J, Zhang X, Farrell JJ, Rynkiewicz MJ, Cannon-Albright LA, Teerlink CC et al..  2019.  Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry.. JAMA Netw Open. 2(3):e191350.
Baker E, Sims R, Leonenko G, Frizzati A, Harwood JC, Grozeva D, Morgan K, Passmore P, Holmes C, Powell J et al..  2019.  Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.. PLoS One. 14(7):e0218111.
Tan CHong, Bonham LW, Fan CChieh, Mormino EC, Sugrue LP, Broce IJ, Hess CP, Yokoyama JS, Rabinovici GD, Miller BL et al..  2019.  Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.. Brain. 142(2):460-470.
Gardner OK, Wang L, Van Booven D, Whitehead PL, Hamilton-Nelson KL, Adams LD, Starks TD, Hofmann NK, Vance JM, Cuccaro ML et al..  2019.  RNA editing alterations in a multi-ethnic Alzheimer disease cohort converge on immune and endocytic molecular pathways.. Hum Mol Genet. 28(18):3053-3061.
Hu Y, Li M, Lu Q, Weng H, Wang J, Zekavat SM, Yu Z, Li B, Gu J, Muchnik S et al..  2019.  A Statistical Framework for Cross-tissue Transcriptome-wide Association Analysis.. Nat Genet. 51(3):568-576.
Katsumata Y, Nelson PT, Estus S, Fardo DW.  2019.  Translating Alzheimer's Disease-associated Polymorphisms into Functional Candidates: a Survey of IGAP Genes and SNPs.. Neurobiol Aging. 74:135-146.
2018
Nafikov RA, Nato AQ, Sohi H, Wang B, Brown L, Horimoto AR, Vardarajan BN, Barral SM, Tosto G, Mayeux RP et al..  2018.  Analysis of Pedigree Data in Populations with Multiple Ancestries: Strategies for Dealing with Admixture in Caribbean Hispanic Families from the ADSP.. Genet Epidemiol. 42(6):500-515.
Rajabli F, Feliciano BE, Celis K, Hamilton-Nelson KL, Whitehead PL, Adams LD, Bussies PL, Manrique CP, Rodriguez A, Rodriguez V et al..  2018.  Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.. PLoS Genet. 14(12):e1007791.
Bonham LW, Karch CM, Fan CC, Tan C, Geier EG, Wang Y, Wen N, Broce IJ, Li Y, Barkovich MJ et al..  2018.  CXCR4 involvement in neurodegenerative diseases.. Transl Psychiatry. 8(1):73.
Lee S, Zhou X, Gao Y, Vardarajan B, Reyes-Dumeyer D, Rajan KB, Wilson RS, Evans DA, Besser LM, Kukull WA et al..  2018.  Episodic memory performance in a multi-ethnic longitudinal study of 13,037 elderly.. PLoS One. 13(11):e0206803.
Blue EE, Bis JC, Dorschner MO, Tsuang DW, Barral SM, Beecham G, Below JE, Bush WS, Butkiewicz M, Cruchaga C et al..  2018.  Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.. Dement Geriatr Cogn Disord. 45(1-2):1-17.
Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CHong, Kouri N, Ross OA, Höglinger GU, Müller U et al..  2018.  Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.. PLoS Med. 15(1):e1002487.
Chen P, Guarino PD, Dysken MW, Pallaki M, Asthana S, Llorente MD, Love S, Vertrees JE, Schellenberg GD, Sano M.  2018.  Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer's Disease: The TEAM-AD VA Cooperative Study.. J Geriatr Psychiatry Neurol. 31(4):177-185.
Lancour D, Naj A, Mayeux R, Haines JL, Pericak-Vance MA, Schellenberg GD, Crovella M, Farrer LA, Kasif S.  2018.  One for all and all for One: Improving replication of genetic studies through network diffusion.. PLoS Genet. 14(4):e1007306.
Sanchez-Contreras MY, Kouri N, Cook CN, Serie DJ, Heckman MG, Finch NCA, Caselli RJ, Uitti RJ, Wszolek ZK, Graff-Radford N et al..  2018.  Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.. Mol Neurodegener. 13(1):37.
Deming Y, Dumitrescu L, Barnes LL, Thambisetty M, Kunkle B, Gifford KA, Bush WS, Chibnik LB, Mukherjee S, De Jager PL et al..  2018.  Sex-specific genetic predictors of Alzheimer's disease biomarkers.. Acta Neuropathol. 136(6):857-872.
Ikezu T, Chen CD, DeLeo AM, Zeldich E, M Fallin D, Kanaan NM, Lunetta KL, Abraham CR, Logue MW, Farrer LA.  2018.  Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans.. J Neuroimmune Pharmacol. 13(2):254-264.
2017
Rehker J, Rodhe J, Nesbitt RR, Boyle EA, Martin BK, Lord J, Karaca I, Naj A, Jessen F, Helisalmi S et al..  2017.  Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants.. PLoS One. 12(10):e0185777.
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL et al..  2017.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.. Mov Disord. 32(6):853-864.
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
Haddick PCG, Larson JL, Rathore N, Bhangale TR, Phung QT, Srinivasan K, Hansen DV, Lill JR, Pericak-Vance MA, Haines J et al..  2017.  A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.. J Alzheimers Dis. 56(3):1037-1054.
Kunkle BW, Vardarajan BN, Naj AC, Whitehead PL, Rolati S, Slifer S, Carney RM, Cuccaro ML, Vance JM, Gilbert JR et al..  2017.  Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport.. JAMA Neurol. 74(9):1113-1122.
Ferrari R, Wang Y, Vandrovcova J, Guelfi S, Witeolar A, Karch CM, Schork AJ, Fan CC, Brewer JB, Momeni P et al..  2017.  Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.. J Neurol Neurosurg Psychiatry. 88(2):152-164.
Desikan RS, Fan CChieh, Wang Y, Schork AJ, Cabral HJ, L Cupples A, Thompson WK, Besser L, Kukull WA, Holland D et al..  2017.  Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.. PLoS Med. 14(3):e1002258.
Monsell SE, Mock C, Fardo DW, Bertelsen S, Cairns NJ, Roe CM, Ellingson SR, Morris JC, Goate AM, Kukull WA.  2017.  Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology.. Alzheimer Dis Assoc Disord. 31(3):232-238.

Pages